
Chinese medical device and healthcare group founded in 1999 and headquartered in Beijing, listed on the Shenzhen Stock Exchange ChiNext board under code 300003 as one of the board's first batch of companies. Started in cardiovascular interventional devices with coronary stents, drug eluting stents and bioresorbable scaffolds and has expanded into structural heart occluders, electrophysiology, in vitro diagnostic reagents and instruments, generic and innovative medicines for cardiovascular and metabolic disease, and artificial intelligence assisted electrocardiogram analysis, supported by manufacturing bases in China and overseas subsidiaries.
회사 프로필 보기
평가 남기기